Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults
A Phase 1 clinical trial enrolled 40 healthy volunteers.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Clinical Trials | COVID-19 | National Institutes of Health (NIH) | Vaccines